Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Telecoms

Daily Deal Round Up: April 20, 2021

Post Holdings led a $25m round for vegetarian meat brand Hungry Planet while Nium and Dataiku added to nine-figure funding totals.


Apr 20, 2021

Oil & gas venturing in Q1 2021

Q1 analysis: Venturing deals still concentrated in non-core areas, more exits reported in the first quarter, average deal size dropped slightly

Apr 20, 2021

Special report: Mission for capturing, storing and using carbon

CO2 is the focus but limiting emissions is hard; capturing, using and storing offers opportunities; but critical under investment in innovation

Apr 20, 2021

Analysis: Groq computes a $300m series C

TDK Ventures and XTX Ventures participated in a sizeable round raised by the advanced computing technology provider Groq at a unicorn valuation. The company is part of the larger artificial intelligence (AI) space, which has seen much and sustained interest by corporates in recent years.

Apr 19, 2021

Astranis ascends with $250m series C

The telecommunications satellite technology developer was valued at $1.4bn in a series C round backed by a Koch Industries subsidiary.

Apr 15, 2021
Apr 15, 2021

Corporate venturing hits record highs

Monthly analysis: March 2021

Apr 15, 2021

Germany ecosystem wobbles

Innovative region: Germany

Apr 15, 2021

Mission for capturing, storing and using carbon

CO2 is the focus but limiting emissions is hard; capturing, using and storing offers opportunities; but critical underinvestment in innovation

Apr 15, 2021

Consumer sector goes through pandemic woes

Sector analysis: Consumer

Apr 15, 2021

Focus on social media and networks

Netherlands-listed technology investor Prosus, formed out of the corporate venturing assets collected by South Africa-listed media group Naspers, has sold 2% of China-based gaming and social media group Tencent for $14.7bn.

Apr 13, 2021

Analysis: Ikena goes public

The oncology drug developer, backed by Bristol Myers Squibb, secured close to $144m in its IPO. This is an exit from a space that has seen much corporate support over the past decade.

Apr 12, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here